PortfoliosLab logoPortfoliosLab logo
CB vs. NVO
Performance
Return for Risk
Drawdowns
Volatility
Dividends
Financials

Performance

CB vs. NVO - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Chubb Limited (CB) and Novo Nordisk A/S (NVO). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

In the year-to-date period, CB achieves a 13.63% return, which is significantly higher than NVO's 0.91% return. Over the past 10 years, CB has outperformed NVO with an annualized return of 12.64%, while NVO has yielded a comparatively lower 8.18% annualized return.


CB

1D
0.11%
1M
9.01%
6M
17.92%
YTD
13.63%
1Y
30.24%
3Y*
22.47%
5Y*
17.51%
10Y*
12.64%
ALL TIME*
11.14%

NVO

1D
-1.41%
1M
14.86%
6M
-17.63%
YTD
0.91%
1Y
-19.26%
3Y*
-13.51%
5Y*
4.43%
10Y*
8.18%
ALL TIME*
14.52%
*Multi-year figures are annualized to reflect compound growth (CAGR)

CB vs. NVO - Yearly Performance Comparison


2026 (YTD)202520242023202220212020201920182017
CB
Chubb Limited
13.63%14.46%23.89%4.20%15.97%27.85%1.41%22.94%-9.63%12.82%
NVO
Novo Nordisk A/S
0.91%-39.22%-15.93%54.84%22.66%63.52%23.33%28.70%-12.98%52.92%

Correlation

The correlation between CB and NVO is -0.05, meaning there is essentially no relationship between their price movements. Each responds to its own set of market drivers, making them strong candidates for combining in a diversified portfolio.


Correlation
Correlation (1Y)
Calculated over the trailing 1-year period

-0.05

Correlation (3Y)
Calculated over the trailing 3-year period

0.08

Correlation (5Y)
Calculated over the trailing 5-year period

0.14

Correlation (10Y)
Calculated over the trailing 10-year period

0.14

Correlation (All Time)
Calculated using the full available price history since Mar 24, 1993

0.17

The correlation between CB and NVO shifts across timeframes, from -0.05 (1 year) to 0.17 (all time), reflecting how their relationship changes across market environments.

Fundamentals

Market Cap

CB:

$136.73B

NVO:

$220.46B

EPS

CB:

$28.45

NVO:

DKK 27.42

PE Ratio

CB:

12.39

NVO:

11.83

PEG Ratio

CB:

0.86

NVO:

0.51

PS Ratio

CB:

2.91

NVO:

4.40

PB Ratio

CB:

1.74

NVO:

7.11

Total Revenue (TTM)

CB:

$48.15B

NVO:

DKK 327.80B

Gross Profit (TTM)

CB:

$17.01B

NVO:

DKK 268.30B

EBITDA (TTM)

CB:

$12.22B

NVO:

DKK 181.54B

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

CB vs. NVO — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

CB
CB Risk / Return Rank: 8787
Overall Rank
CB Sharpe Ratio Rank: 8787
Sharpe Ratio Rank
CB Sortino Ratio Rank: 8686
Sortino Ratio Rank
CB Omega Ratio Rank: 8484
Omega Ratio Rank
CB Calmar Ratio Rank: 8888
Calmar Ratio Rank
CB Martin Ratio Rank: 8989
Martin Ratio Rank

NVO
NVO Risk / Return Rank: 3030
Overall Rank
NVO Sharpe Ratio Rank: 2929
Sharpe Ratio Rank
NVO Sortino Ratio Rank: 2929
Sortino Ratio Rank
NVO Omega Ratio Rank: 2929
Omega Ratio Rank
NVO Calmar Ratio Rank: 3232
Calmar Ratio Rank
NVO Martin Ratio Rank: 3333
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

CB vs. NVO - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Chubb Limited (CB) and Novo Nordisk A/S (NVO). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.


CBNVODifference
Sharpe ratioReturn per unit of total volatility

+1.99

Sortino ratioReturn per unit of downside risk

+2.60

Omega ratioGain probability vs. loss probability

1.29

0.97

+0.32

Calmar ratioReturn relative to maximum drawdown

3.25

-0.39

+3.64

Martin ratioReturn relative to average drawdown

8.75

-0.61

+9.36

CB vs. NVO - Sharpe Ratio Comparison

The current CB Sharpe Ratio is 1.62, which is higher than the NVO Sharpe Ratio of -0.37. The chart below compares the historical Sharpe Ratios of CB and NVO, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Drawdowns

CB vs. NVO - Drawdown Comparison

The maximum CB drawdown since its inception was -50.99%, smaller than the maximum NVO drawdown of -74.70%. Use the drawdown chart below to compare losses from any high point for CB and NVO.


Loading charts...

Drawdown Indicators


CBNVODifference

Max Drawdown

Largest peak-to-trough decline

-50.99%

-74.70%

+23.71%

Max Drawdown (1Y)

Largest decline over 1 year

-9.36%

-49.17%

+39.81%

Max Drawdown (3Y)

Largest decline over 3 years

-14.35%

-74.70%

+60.35%

Max Drawdown (5Y)

Largest decline over 5 years

-19.26%

-74.70%

+55.44%

Max Drawdown (10Y)

Largest decline over 10 years

-42.59%

-74.70%

+32.11%

Current Drawdown

Current decline from peak

-2.39%

-63.95%

+61.56%

Average Drawdown

Average peak-to-trough decline

-10.65%

-17.89%

+7.24%

Ulcer Index

Depth and duration of drawdowns from previous peaks

3.47%

31.75%

-28.28%

Volatility

CB vs. NVO - Volatility Comparison

The current volatility for Chubb Limited (CB) is 8.47%, while Novo Nordisk A/S (NVO) has a volatility of 9.48%. This indicates that CB experiences smaller price fluctuations and is considered to be less risky than NVO based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


CBNVODifference

Volatility (1M)

Calculated over the trailing 1-month period

8.47%

9.48%

-1.01%

Volatility (6M)

Calculated over the trailing 6-month period

14.42%

37.43%

-23.01%

Volatility (1Y)

Calculated over the trailing 1-year period

18.80%

51.79%

-32.99%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

20.27%

38.58%

-18.31%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

23.75%

32.63%

-8.88%

Dividends

CB vs. NVO - Dividend Comparison

CB's dividend yield for the trailing twelve months is around 1.11%, less than NVO's 3.63% yield.


PositionTTM20252024202320222021202020192018201720162015
CB
Chubb Limited
1.11%1.22%1.30%1.51%1.49%1.65%2.01%1.91%2.24%1.93%2.07%4.23%
NVO
Novo Nordisk A/S
3.63%3.31%1.68%1.00%1.20%1.35%1.87%2.14%1.45%1.52%2.87%0.92%

Financials

CB vs. NVO - Financials Comparison

This section allows you to compare key financial metrics between Chubb Limited and Novo Nordisk A/S. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


0.0020.00B40.00B60.00B80.00B100.00BJulyOctober2022AprilJulyOctober2023AprilJulyOctober2024AprilJulyOctober2025AprilJulyOctober2026
1.88B
96.82B
(CB) Total Revenue
(NVO) Total Revenue
Please note, different currencies. CB values in USD, NVO values in DKK

Frequently Asked Questions


CB and NVO have a correlation of -0.05, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

NVO has higher volatility (9.48%) compared to CB (8.47%). In terms of maximum drawdown, CB dropped -50.99% vs NVO's -74.70%.

CB currently has the higher Sharpe Ratio (1.62 vs -0.37), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.

Portfolio Optimizer

Find the right allocation for CB and NVO

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer